KYOWA KIRIN CO. LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,668 JPY | 0.00% |
|
+1.43% | +12.55% |
| 07:26am | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
| 02/05 | BridgeBio Pharma Shares Decline After Q1 Financial Results | MT |
ETFs positioned on Kyowa Kirin Co. Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.22% | 15 M€ | +11.75% | ||
| 0.44% | 11 M€ | +13.64% | - | |
| 0.41% | 251 M€ | +13.17% | ||
| 0.39% | 31,732 M€ | +15.18% | - | |
| 0.39% | 1,198 M€ | +14.37% | - | |
| 0.36% | 67,864 M€ | +15.20% | ||
| 0.36% | 16,729 M€ | +14.33% | - | |
| 0.30% | 26 M€ | +21.71% | ||
| 0.27% | 4 M€ | +16.67% | ||
| 0.27% | 81 M€ | +15.99% | ||
| 0.26% | 73 M€ | +18.87% | ||
| 0.23% | 60 M€ | +16.25% | ||
| 0.17% | 5,115 M€ | +16.14% | ||
| 0.17% | 10,207 M€ | +16.36% | ||
| 0.15% | 18 M€ | +16.15% | - | |
| 0.15% | 5 M€ | +10.09% | - | |
| 0.15% | 14 M€ | +5.66% | - | |
| 0.15% | 14 M€ | +18.73% | ||
| 0.13% | 20,721 M€ | +15.40% | - | |
| 0.13% | 144,586 M€ | +16.55% | ||
| 0.13% | 66,066 M€ | +16.86% | - | |
| 0.12% | 29 M€ | +8.37% | - | |
| 0.10% | 469 M€ | -2.05% | - | |
| 0.10% | 3,859 M€ | +18.82% | - | |
| 0.09% | 4 M€ | -.--% | - | |
| 0.03% | 7 M€ | +0.11% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.03% | 7 M€ | +3.48% | - | |
| 0.02% | 277 M€ | -.--% | - |
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
07/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,668
JPY
Average target price
3,050
JPY
Spread / Average Target
+14.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.55% | 9.3B | |
| +5.20% | 71.19B | |
| -13.75% | 5.01B | |
| +42.38% | 4.47B | |
| +4.51% | 3.96B | |
| +21.10% | 2.44B | |
| -19.05% | 2.41B | |
| -28.72% | 2.23B | |
| +11.13% | 2.02B | |
| +6.53% | 1.69B |
- Stock Market
- Equities
- 4151 Stock
- Funds and ETFs Kyowa Kirin Co. Ltd.